Clinical Trial

Super-voltage PRF of Stellate Ganglion Versus Super-voltage PRF of T2 T3 Sympathetic Ganglia in Managing PMPS.

Name: Super-voltage PRF of Stellate Ganglion Versus Super-voltage PRF of T2 T3 Sympathetic Ganglia in Managing PMPS. — clinical trial record (NCT07675096)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PMPS PRF

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this study is to compare the effectiveness of super-voltage pulsed radiofrequency of stellate ganglion and super-voltage pulsed radiofrequency of T2-T3 sympathetic ganglia in the treatment of postmastectomy pain syndrome.

Trial Details

NCT Number	NCT07675096
Lead Sponsor	National Cancer Institute, Egypt
Conditions	Post Mastectomy Pain Syndrome, Chronic Pain Following Surgical Procedure for Cancer
Enrollment	75 participants
Start Date	2026-07-01
Primary Completion	2027-07-30 (estimated)
Study Completion	2027-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-30